FreeStyle Libre

Discussion in 'Abbott' started by Anonymous, Oct 25, 2014 at 5:44 PM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    I think there is some confusion here. Looks like we have one repeat poster here who is talking up Libre. Reality this person is British, and has been posting European numbers. For all of us here, on this USA site, those numbers the poster boasts about are shockingly insignificant. The poster appears lost, positing on a US site about European topics.

    To the poster: perhaps you are hoping to be positive and encouraging with your repeated post about Libre over there. But keep mind the perspective from this side of "the pond", as you British so quaintly say. First, it is common knowledge here (but appears to be news to you) that Libre in Europe is a test market. Second, it is common knowledge here that Abbott had to the test market outside the US because they don't have US FDA approval. Thirst, it is common knowledge here that Abbott is underwriting a significant portion of the cost to patients in Europe. Last, the numbers you share would, in the USA, be considered a failure, even if they were sales in just one medium size US city, like Milwaukee, or St, Louis.

    Not to be rude, but I think everyone here has made very clear to you this fact: we don't care. Don't you have a web site over there you can post to? To people like you, who might care?
     

  2. anonymous

    anonymous Guest

    I am not a "Libre Booster". It's just the facts. I leave the rah rah crap to libre boy/girl. I just follow what's going on with Abbott (all divisions) to decided if I will buy more stock. Made money....Right now my main concern is the St. Jude merger.

    You are obviously part of the competition who bad mouths a good product or just some disgruntled former/current employee.
     
  3. anonymous

    anonymous Guest

    1) 200K Libre users. At $70 a sensor and at one sensor a month about $168M/yr revenue.
    2) Acceptance rate of product is a steep ramp. Adding about 50K or more users per quarter.
    3) ADC European sales up 20% due to Libre. Total ADC sales double digit due to Libre.
    4) Libre Pro now in US.
    5) Libre Consumer version should have approval in US by Q2 2017. FDA says that the Pro approval process "paved the way for the consumer version by 75%".

    LibreMan in the UK
     
  4. anonymous

    anonymous Guest

    Answers to your "points" above:
    1). Irrelevant: pure conjecture, file under "I want what you're drinking"
    2). Sales? It's a heavily subsidized test market, to cash customers ... pull that plug, it's dead. Not covered by your communist, er "socialist", healthcare
    3). Insignificant (see above): ADC looses money in every "sales"
    4). Insignificant: Hospital use only, sales projections will not off-set ADC USA continued eroding sales and market share
    5). "Should"? ... "Hope is not a strategy"; James Kilts (look it up)

    Man, you are pathetic!
     
  5. anonymous

    anonymous Guest

    And you sir are full of Fucking Bullshit. True is truth and you have so much hate for this company that you are blind to the facts.
     
  6. anonymous

    anonymous Guest

    You have your Irish head so far up your arse that your brain has run out of oxygen. You have established that you don't work for the company by your ignorance of all fact. Why we continue to try to correct you I don't know. How can you comment on a company you have no connection to, except some kind of self-admitted emotional attachment to Libre? We work here, and our financial security is linked to ADC and Abbott. We want, need, and are committed to Abbott's success. We come here to vent, or commiserate. This the our private water cooler; no BS allowed. You have some perverted fairy tale notion that coming and re-posting propaganda and press releases we all have heard and seen, and then coming back repeatedly to repost excerpts of the same nonsense, will some how do what? Keep Libre alive over there so you can buy it? Get lost!
     
  7. anonymous

    anonymous Guest

    I have worked for Abbott for 12 years and still work here. Strips became a commodity item and the R&D group in Alameda was asked in 2008 to come up with something. We in the strip chem group were asked to help. Alameda came up with the early versions of Libre based on the second Navigator product. It took years for the CGM group and the meter group to come up with good inexpensive designs. The sensor group needed to improve on the current CGM sensor and it did with the help of Alameda chemists who now work in the UK. Libre happened because of all the competition from other companies in the strip business.

    Facts are simple. It worked. ADC is replacing lost strip revenue with Libre sensor revenue. I know what the senors cost to make, I know approximately what we ship. Yield is still a bit of a problem sometimes but overall Abbott makes money. Say what you like, truth is truth. I will post again when Libre is selling well in the US.

    Good day gentleman.
     
  8. anonymous

    anonymous Guest

    Top of the mornin' to you, ladie! See, yere givin it away, lassie, ta cash payin' patients only, over there is I'reland. It's a test, Lassie, what we call a trial run. It may be the cat's meow, but it ain't makin no money fer us. Now, don't cry Lassie; ye can go one belevin the wee leprechauns are makin it fer ya. And there's a pot a gold at the end of the rainbow.

    Now, you come back, like ya say (we're gonna hold ya ta ya word, Lassie), when Libre is sellin well here in the USA. And not the Pro version now; we're takin the real ting here. We'll be lookin fer ya around 2020 or so.

    Now, doncha let the door hit ya in ya arse on the way out.
     
  9. anonymous

    anonymous Guest


    OK USA ADC TROLL YER FULL O SHITE
     
  10. anonymous

    anonymous Guest

    Hey, what year is it??? 2025? Did we just go through a time warp?

    Didn't you promise not to come back until Libre was launched and outselling BGM in the US?
     
  11. anonymous

    anonymous Guest

    Oh, one more thing: isn't an internet troll something like a real life stalker? Doesn't that definition fit you pretty well? Considering that you're in Ireland (this is a USA board), have no connection to Abbott, and come on this and the other main ADC thread to post company propaganda?

    BTW, these are rhetorical questions.
     
  12. anonymous

    anonymous Guest

    You idiot, last posters are both in USA. You been duped and fell for it like a sheep
    2 FUNNI ....heard Nancy Berce and WiPRO have reduced wait time on IT dept ticket requests by 30% AND saved 40% in salarys. Quicker respnnse for less $$$ Smart Move
     
  13. anonymous

    anonymous Guest

    This isn't just a USA board you dip shit. 1/3 of traffic here is from India and other foreign country's. Honestly how clueless and stupid some folks can be.
     
  14. anonymous

    anonymous Guest

    Launch is exceeding expectations!!!
     
  15. anonymous

    anonymous Guest

    WOW! Three posts in a row ... within a few hours AFTER vowing not to return until 2025. Add that to your other half dozen posts today.

    Does your word mean anything?

    It you don't honor your own words with action, why would anyone else believe anything you have to say?

    Like they say, if you don't have your honor, you have nothing.

    Now do the honorable thing. Goodbye, Libre Boy!
     
  16. anonymous

    anonymous Guest

    Looks like the two posts you are referring to ARE from the USA, since both seem to be clearly responding to LibreBoy, who IS in the UK.

    Your next post, about India etc, is incorrect in that this is indeed a board formed for US pharma sales reps to be able to vent in confidence, an electronic water cooler. There seem to be a few occasional posts from India, a few more from the EK, but probably 98% of the those who come here are USA. As many others have pointed out, to be blunt, we have enough issues here, we just don't care about "water cooler" talk from those places.
     
  17. anonymous

    anonymous Guest

    A little harsh, dude. Not that any of us want to see her dribble, but she's harmless. Didn't she admit to being an english diabetic who likes Libra, and is afraid it will be discontinued, so she comes here thinking talking it up to us will somehow prevent that?
     
  18. anonymous

    anonymous Guest

    I feel sort of bad for libreboy, or girl, whatever. I picture a struggling mom or dad of a diabetic child, living on one of those dreary endless apartment developments you see on TV over there, who received Libre in Ireland or wherever as part of the test, and it's helped. Now she's afraid when the test ends because she won't be able to afford it unsubsidized. They've got government healthcare, which must be horrible. I wouldn't want the DMV controlling my healthcare, but I guess that's where we're headed.

    So Libreboy is pathetic in a sad way.
     
  19. anonymous

    anonymous Guest

    What launch?? Gosh, did I miss something???